OraSure Technologies, Inc.
Get $10 bonus on your first $100 deposit for OSUR
Get $10 bonus on your first $100 deposit for OSUR
OraSure Technologies, Inc. (OSUR) Stock Competitors & Peer Comparison
See (OSUR) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OSUR | $2.96 | -3.27% | 204.6M | -3.15 | -$0.94 | N/A |
| ISRG | $450.62 | -0.95% | 160B | 57.33 | $7.86 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 21.44 | $2.76 | +2.29% |
| BDX | $154.22 | -0.80% | 55.9B | 25.16 | $6.13 | +2.29% |
| ALC | $78.01 | +0.79% | 38B | 39.39 | $1.98 | +0.43% |
| MDLN | $45.60 | -0.20% | 37B | 31.02 | $1.47 | N/A |
| RMD | $228.87 | +0.39% | 33.4B | 22.66 | $10.10 | +1.02% |
| WST | $256.55 | -0.77% | 18.5B | 37.77 | $6.79 | +0.34% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| COO | $71.21 | -0.35% | 13.9B | 35.43 | $2.01 | N/A |
Stock Comparison
OSUR vs ISRG Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, ISRG has a market cap of 160B. Regarding current trading prices, OSUR is priced at $2.96, while ISRG trades at $450.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas ISRG's P/E ratio is 57.33. In terms of profitability, OSUR's ROE is -0.19%, compared to ISRG's ROE of +0.16%. Regarding short-term risk, OSUR is more volatile compared to ISRG. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check ISRG's competition here
OSUR vs BDXA Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, OSUR is priced at $2.96, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas BDXA's P/E ratio is 21.44. In terms of profitability, OSUR's ROE is -0.19%, compared to BDXA's ROE of +0.07%. Regarding short-term risk, OSUR is more volatile compared to BDXA. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check BDXA's competition here
OSUR vs BDX Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, BDX has a market cap of 55.9B. Regarding current trading prices, OSUR is priced at $2.96, while BDX trades at $154.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas BDX's P/E ratio is 25.16. In terms of profitability, OSUR's ROE is -0.19%, compared to BDX's ROE of +0.07%. Regarding short-term risk, OSUR is more volatile compared to BDX. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check BDX's competition here
OSUR vs ALC Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, ALC has a market cap of 38B. Regarding current trading prices, OSUR is priced at $2.96, while ALC trades at $78.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas ALC's P/E ratio is 39.39. In terms of profitability, OSUR's ROE is -0.19%, compared to ALC's ROE of +0.04%. Regarding short-term risk, OSUR is more volatile compared to ALC. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check ALC's competition here
OSUR vs MDLN Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, MDLN has a market cap of 37B. Regarding current trading prices, OSUR is priced at $2.96, while MDLN trades at $45.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas MDLN's P/E ratio is 31.02. In terms of profitability, OSUR's ROE is -0.19%, compared to MDLN's ROE of +0.08%. Regarding short-term risk, OSUR is more volatile compared to MDLN. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check MDLN's competition here
OSUR vs RMD Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, RMD has a market cap of 33.4B. Regarding current trading prices, OSUR is priced at $2.96, while RMD trades at $228.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas RMD's P/E ratio is 22.66. In terms of profitability, OSUR's ROE is -0.19%, compared to RMD's ROE of +0.25%. Regarding short-term risk, OSUR is more volatile compared to RMD. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check RMD's competition here
OSUR vs WST Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, WST has a market cap of 18.5B. Regarding current trading prices, OSUR is priced at $2.96, while WST trades at $256.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas WST's P/E ratio is 37.77. In terms of profitability, OSUR's ROE is -0.19%, compared to WST's ROE of +0.17%. Regarding short-term risk, OSUR is more volatile compared to WST. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check WST's competition here
OSUR vs HOLX Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, OSUR is priced at $2.96, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas HOLX's P/E ratio is 31.54. In terms of profitability, OSUR's ROE is -0.19%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, OSUR is more volatile compared to HOLX. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check HOLX's competition here
OSUR vs COO Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, COO has a market cap of 13.9B. Regarding current trading prices, OSUR is priced at $2.96, while COO trades at $71.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas COO's P/E ratio is 35.43. In terms of profitability, OSUR's ROE is -0.19%, compared to COO's ROE of +0.05%. Regarding short-term risk, OSUR is more volatile compared to COO. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check COO's competition here
OSUR vs BDXB Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, OSUR is priced at $2.96, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas BDXB's P/E ratio is 7.60. In terms of profitability, OSUR's ROE is -0.19%, compared to BDXB's ROE of +0.07%. Regarding short-term risk, OSUR is more volatile compared to BDXB. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check BDXB's competition here
OSUR vs MASI Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, MASI has a market cap of 9.3B. Regarding current trading prices, OSUR is priced at $2.96, while MASI trades at $178.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas MASI's P/E ratio is 46.56. In terms of profitability, OSUR's ROE is -0.19%, compared to MASI's ROE of -0.17%. Regarding short-term risk, OSUR is more volatile compared to MASI. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check MASI's competition here
OSUR vs BAX Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, BAX has a market cap of 8.8B. Regarding current trading prices, OSUR is priced at $2.96, while BAX trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas BAX's P/E ratio is -9.80. In terms of profitability, OSUR's ROE is -0.19%, compared to BAX's ROE of -0.14%. Regarding short-term risk, OSUR is more volatile compared to BAX. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check BAX's competition here
OSUR vs ATR Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, ATR has a market cap of 8.5B. Regarding current trading prices, OSUR is priced at $2.96, while ATR trades at $131.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas ATR's P/E ratio is 22.32. In terms of profitability, OSUR's ROE is -0.19%, compared to ATR's ROE of +0.15%. Regarding short-term risk, OSUR is more volatile compared to ATR. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check ATR's competition here
OSUR vs RGEN Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, RGEN has a market cap of 6.8B. Regarding current trading prices, OSUR is priced at $2.96, while RGEN trades at $120.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas RGEN's P/E ratio is 139.65. In terms of profitability, OSUR's ROE is -0.19%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, OSUR is more volatile compared to RGEN. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check RGEN's competition here
OSUR vs BLCO Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, BLCO has a market cap of 5.8B. Regarding current trading prices, OSUR is priced at $2.96, while BLCO trades at $16.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas BLCO's P/E ratio is -16.16. In terms of profitability, OSUR's ROE is -0.19%, compared to BLCO's ROE of -0.06%. Regarding short-term risk, OSUR is more volatile compared to BLCO. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check BLCO's competition here
OSUR vs AVTR Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, AVTR has a market cap of 5.4B. Regarding current trading prices, OSUR is priced at $2.96, while AVTR trades at $7.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas AVTR's P/E ratio is -10.12. In terms of profitability, OSUR's ROE is -0.19%, compared to AVTR's ROE of -0.09%. Regarding short-term risk, OSUR is more volatile compared to AVTR. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check AVTR's competition here
OSUR vs TFX Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, TFX has a market cap of 5.2B. Regarding current trading prices, OSUR is priced at $2.96, while TFX trades at $118.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas TFX's P/E ratio is 89.78. In terms of profitability, OSUR's ROE is -0.19%, compared to TFX's ROE of -0.24%. Regarding short-term risk, OSUR is more volatile compared to TFX. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check TFX's competition here
OSUR vs MMSI Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, MMSI has a market cap of 4.1B. Regarding current trading prices, OSUR is priced at $2.96, while MMSI trades at $68.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas MMSI's P/E ratio is 32.05. In terms of profitability, OSUR's ROE is -0.19%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, OSUR is more volatile compared to MMSI. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check MMSI's competition here
OSUR vs STVN Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, STVN has a market cap of 3.7B. Regarding current trading prices, OSUR is priced at $2.96, while STVN trades at $13.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas STVN's P/E ratio is 22.93. In terms of profitability, OSUR's ROE is -0.19%, compared to STVN's ROE of +0.10%. Regarding short-term risk, OSUR is more volatile compared to STVN. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check STVN's competition here
OSUR vs ICUI Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, ICUI has a market cap of 3.1B. Regarding current trading prices, OSUR is priced at $2.96, while ICUI trades at $125.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas ICUI's P/E ratio is 4189.33. In terms of profitability, OSUR's ROE is -0.19%, compared to ICUI's ROE of +0.00%. Regarding short-term risk, OSUR is more volatile compared to ICUI. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check ICUI's competition here
OSUR vs HAE Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, HAE has a market cap of 2.7B. Regarding current trading prices, OSUR is priced at $2.96, while HAE trades at $57.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas HAE's P/E ratio is 15.80. In terms of profitability, OSUR's ROE is -0.19%, compared to HAE's ROE of +0.20%. Regarding short-term risk, OSUR is more volatile compared to HAE. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check HAE's competition here
OSUR vs LMAT Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, LMAT has a market cap of 2.6B. Regarding current trading prices, OSUR is priced at $2.96, while LMAT trades at $114.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas LMAT's P/E ratio is 45.48. In terms of profitability, OSUR's ROE is -0.19%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, OSUR is more volatile compared to LMAT. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check LMAT's competition here
OSUR vs WRBY Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, WRBY has a market cap of 2.6B. Regarding current trading prices, OSUR is priced at $2.96, while WRBY trades at $20.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas WRBY's P/E ratio is 2083.00. In terms of profitability, OSUR's ROE is -0.19%, compared to WRBY's ROE of +0.00%. Regarding short-term risk, OSUR is more volatile compared to WRBY. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check WRBY's competition here
OSUR vs XRAY Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, XRAY has a market cap of 2.3B. Regarding current trading prices, OSUR is priced at $2.96, while XRAY trades at $11.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas XRAY's P/E ratio is -3.94. In terms of profitability, OSUR's ROE is -0.19%, compared to XRAY's ROE of -0.35%. Regarding short-term risk, OSUR is more volatile compared to XRAY. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check XRAY's competition here
OSUR vs ATRC Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, ATRC has a market cap of 1.4B. Regarding current trading prices, OSUR is priced at $2.96, while ATRC trades at $28.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas ATRC's P/E ratio is -117.62. In terms of profitability, OSUR's ROE is -0.19%, compared to ATRC's ROE of -0.02%. Regarding short-term risk, OSUR is more volatile compared to ATRC. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check ATRC's competition here
OSUR vs STAA Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, STAA has a market cap of 1.3B. Regarding current trading prices, OSUR is priced at $2.96, while STAA trades at $26.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas STAA's P/E ratio is -16.32. In terms of profitability, OSUR's ROE is -0.19%, compared to STAA's ROE of -0.23%. Regarding short-term risk, OSUR is more volatile compared to STAA. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check STAA's competition here
OSUR vs PLSE Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, PLSE has a market cap of 1.3B. Regarding current trading prices, OSUR is priced at $2.96, while PLSE trades at $18.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas PLSE's P/E ratio is -17.29. In terms of profitability, OSUR's ROE is -0.19%, compared to PLSE's ROE of -0.73%. Regarding short-term risk, OSUR is less volatile compared to PLSE. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check PLSE's competition here
OSUR vs NVCR Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, NVCR has a market cap of 1.2B. Regarding current trading prices, OSUR is priced at $2.96, while NVCR trades at $10.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas NVCR's P/E ratio is -8.67. In terms of profitability, OSUR's ROE is -0.19%, compared to NVCR's ROE of -0.39%. Regarding short-term risk, OSUR is more volatile compared to NVCR. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check NVCR's competition here
OSUR vs NNNN Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, NNNN has a market cap of 1.2B. Regarding current trading prices, OSUR is priced at $2.96, while NNNN trades at $27.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas NNNN's P/E ratio is 451.67. In terms of profitability, OSUR's ROE is -0.19%, compared to NNNN's ROE of +0.11%. Regarding short-term risk, OSUR is more volatile compared to NNNN. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check NNNN's competition here
OSUR vs KMTS Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, KMTS has a market cap of 1B. Regarding current trading prices, OSUR is priced at $2.96, while KMTS trades at $17.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas KMTS's P/E ratio is -3.27. In terms of profitability, OSUR's ROE is -0.19%, compared to KMTS's ROE of -0.69%. Regarding short-term risk, OSUR is less volatile compared to KMTS. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check KMTS's competition here
OSUR vs AZTA Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, AZTA has a market cap of 1B. Regarding current trading prices, OSUR is priced at $2.96, while AZTA trades at $22.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas AZTA's P/E ratio is 38.29. In terms of profitability, OSUR's ROE is -0.19%, compared to AZTA's ROE of -0.03%. Regarding short-term risk, OSUR is more volatile compared to AZTA. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check AZTA's competition here
OSUR vs BLFS Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, BLFS has a market cap of 953.4M. Regarding current trading prices, OSUR is priced at $2.96, while BLFS trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas BLFS's P/E ratio is -78.96. In terms of profitability, OSUR's ROE is -0.19%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, OSUR is less volatile compared to BLFS. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check BLFS's competition here
OSUR vs QDEL Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, QDEL has a market cap of 942.9M. Regarding current trading prices, OSUR is priced at $2.96, while QDEL trades at $13.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas QDEL's P/E ratio is -0.83. In terms of profitability, OSUR's ROE is -0.19%, compared to QDEL's ROE of -0.46%. Regarding short-term risk, OSUR is more volatile compared to QDEL. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check QDEL's competition here
OSUR vs ATRI Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, OSUR is priced at $2.96, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas ATRI's P/E ratio is 64.50. In terms of profitability, OSUR's ROE is -0.19%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, OSUR is more volatile compared to ATRI. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check ATRI's competition here
OSUR vs ANGO Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, ANGO has a market cap of 404.9M. Regarding current trading prices, OSUR is priced at $2.96, while ANGO trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas ANGO's P/E ratio is -12.89. In terms of profitability, OSUR's ROE is -0.19%, compared to ANGO's ROE of -0.18%. Regarding short-term risk, OSUR is more volatile compared to ANGO. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check ANGO's competition here
OSUR vs UTMD Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, UTMD has a market cap of 211.1M. Regarding current trading prices, OSUR is priced at $2.96, while UTMD trades at $65.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas UTMD's P/E ratio is 18.94. In terms of profitability, OSUR's ROE is -0.19%, compared to UTMD's ROE of +0.10%. Regarding short-term risk, OSUR is more volatile compared to UTMD. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check UTMD's competition here
OSUR vs KRMD Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, KRMD has a market cap of 195.2M. Regarding current trading prices, OSUR is priced at $2.96, while KRMD trades at $4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas KRMD's P/E ratio is -70.17. In terms of profitability, OSUR's ROE is -0.19%, compared to KRMD's ROE of -0.16%. Regarding short-term risk, OSUR is more volatile compared to KRMD. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check KRMD's competition here
OSUR vs INFU Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, INFU has a market cap of 191.1M. Regarding current trading prices, OSUR is priced at $2.96, while INFU trades at $9.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas INFU's P/E ratio is 30.31. In terms of profitability, OSUR's ROE is -0.19%, compared to INFU's ROE of +0.12%. Regarding short-term risk, OSUR is more volatile compared to INFU. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check INFU's competition here
OSUR vs STXS Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, STXS has a market cap of 181.4M. Regarding current trading prices, OSUR is priced at $2.96, while STXS trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas STXS's P/E ratio is -7.46. In terms of profitability, OSUR's ROE is -0.19%, compared to STXS's ROE of -1.92%. Regarding short-term risk, OSUR is less volatile compared to STXS. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check STXS's competition here
OSUR vs PDEX Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, PDEX has a market cap of 167.9M. Regarding current trading prices, OSUR is priced at $2.96, while PDEX trades at $51.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas PDEX's P/E ratio is 15.10. In terms of profitability, OSUR's ROE is -0.19%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, OSUR is more volatile compared to PDEX. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check PDEX's competition here
OSUR vs SMTI Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, SMTI has a market cap of 151.5M. Regarding current trading prices, OSUR is priced at $2.96, while SMTI trades at $16.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas SMTI's P/E ratio is -330.60. In terms of profitability, OSUR's ROE is -0.19%, compared to SMTI's ROE of -1.79%. Regarding short-term risk, OSUR is more volatile compared to SMTI. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check SMTI's competition here
OSUR vs MBOT Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, MBOT has a market cap of 118M. Regarding current trading prices, OSUR is priced at $2.96, while MBOT trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas MBOT's P/E ratio is -8.63. In terms of profitability, OSUR's ROE is -0.19%, compared to MBOT's ROE of -0.24%. Regarding short-term risk, OSUR is less volatile compared to MBOT. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check MBOT's competition here
OSUR vs NYXH Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, NYXH has a market cap of 106.8M. Regarding current trading prices, OSUR is priced at $2.96, while NYXH trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas NYXH's P/E ratio is -1.05. In terms of profitability, OSUR's ROE is -0.19%, compared to NYXH's ROE of -1.35%. Regarding short-term risk, OSUR is more volatile compared to NYXH. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check NYXH's competition here
OSUR vs AKYA Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, OSUR is priced at $2.96, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas AKYA's P/E ratio is -1.34. In terms of profitability, OSUR's ROE is -0.19%, compared to AKYA's ROE of -27.96%. Regarding short-term risk, OSUR is more volatile compared to AKYA. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check AKYA's competition here
OSUR vs ZTEK Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, ZTEK has a market cap of 57.5M. Regarding current trading prices, OSUR is priced at $2.96, while ZTEK trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas ZTEK's P/E ratio is -8.92. In terms of profitability, OSUR's ROE is -0.19%, compared to ZTEK's ROE of -0.61%. Regarding short-term risk, OSUR is less volatile compared to ZTEK. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check ZTEK's competition here
OSUR vs OMIC Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, OSUR is priced at $2.96, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas OMIC's P/E ratio is -0.58. In terms of profitability, OSUR's ROE is -0.19%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, OSUR is more volatile compared to OMIC. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check OMIC's competition here
OSUR vs IGAP Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, OSUR is priced at $2.96, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas IGAP's P/E ratio is -10.52. In terms of profitability, OSUR's ROE is -0.19%, compared to IGAP's ROE of +0.00%. Regarding short-term risk, OSUR is more volatile compared to IGAP. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check IGAP's competition here
OSUR vs DXR Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, DXR has a market cap of 47.7M. Regarding current trading prices, OSUR is priced at $2.96, while DXR trades at $9.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas DXR's P/E ratio is 5.57. In terms of profitability, OSUR's ROE is -0.19%, compared to DXR's ROE of +0.22%. Regarding short-term risk, OSUR is more volatile compared to DXR. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check DXR's competition here
OSUR vs STSS Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, STSS has a market cap of 42.6M. Regarding current trading prices, OSUR is priced at $2.96, while STSS trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas STSS's P/E ratio is -0.16. In terms of profitability, OSUR's ROE is -0.19%, compared to STSS's ROE of -1.56%. Regarding short-term risk, OSUR is more volatile compared to STSS. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check STSS's competition here
OSUR vs NEPH Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, NEPH has a market cap of 31.5M. Regarding current trading prices, OSUR is priced at $2.96, while NEPH trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas NEPH's P/E ratio is 26.91. In terms of profitability, OSUR's ROE is -0.19%, compared to NEPH's ROE of +0.12%. Regarding short-term risk, OSUR is less volatile compared to NEPH. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check NEPH's competition here
OSUR vs POCI Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, POCI has a market cap of 31.2M. Regarding current trading prices, OSUR is priced at $2.96, while POCI trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas POCI's P/E ratio is -4.33. In terms of profitability, OSUR's ROE is -0.19%, compared to POCI's ROE of -0.61%. Regarding short-term risk, OSUR is less volatile compared to POCI. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check POCI's competition here
OSUR vs SDC Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, OSUR is priced at $2.96, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas SDC's P/E ratio is -0.03. In terms of profitability, OSUR's ROE is -0.19%, compared to SDC's ROE of -1.96%. Regarding short-term risk, OSUR is less volatile compared to SDC. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check SDC's competition here
OSUR vs IVC Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, OSUR is priced at $2.96, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas IVC's P/E ratio is -0.79. In terms of profitability, OSUR's ROE is -0.19%, compared to IVC's ROE of -0.46%. Regarding short-term risk, OSUR is more volatile compared to IVC. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check IVC's competition here
OSUR vs MLSS Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, MLSS has a market cap of 22.1M. Regarding current trading prices, OSUR is priced at $2.96, while MLSS trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas MLSS's P/E ratio is -3.93. In terms of profitability, OSUR's ROE is -0.19%, compared to MLSS's ROE of -1.74%. Regarding short-term risk, OSUR is more volatile compared to MLSS. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check MLSS's competition here
OSUR vs EKSO Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, EKSO has a market cap of 21.9M. Regarding current trading prices, OSUR is priced at $2.96, while EKSO trades at $9.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas EKSO's P/E ratio is -1.91. In terms of profitability, OSUR's ROE is -0.19%, compared to EKSO's ROE of -1.11%. Regarding short-term risk, OSUR is less volatile compared to EKSO. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check EKSO's competition here
OSUR vs RVP Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, RVP has a market cap of 20.2M. Regarding current trading prices, OSUR is priced at $2.96, while RVP trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas RVP's P/E ratio is -1.57. In terms of profitability, OSUR's ROE is -0.19%, compared to RVP's ROE of -0.17%. Regarding short-term risk, OSUR is more volatile compared to RVP. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check RVP's competition here
OSUR vs HBIO Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, HBIO has a market cap of 19.3M. Regarding current trading prices, OSUR is priced at $2.96, while HBIO trades at $4.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas HBIO's P/E ratio is -0.34. In terms of profitability, OSUR's ROE is -0.19%, compared to HBIO's ROE of -3.89%. Regarding short-term risk, OSUR is less volatile compared to HBIO. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check HBIO's competition here
OSUR vs ZJYL Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, ZJYL has a market cap of 18.1M. Regarding current trading prices, OSUR is priced at $2.96, while ZJYL trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas ZJYL's P/E ratio is 11.55. In terms of profitability, OSUR's ROE is -0.19%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, OSUR is less volatile compared to ZJYL. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check ZJYL's competition here
OSUR vs RGNT Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, RGNT has a market cap of 12.2M. Regarding current trading prices, OSUR is priced at $2.96, while RGNT trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas RGNT's P/E ratio is -0.13. In terms of profitability, OSUR's ROE is -0.19%, compared to RGNT's ROE of N/A. Regarding short-term risk, OSUR is more volatile compared to RGNT. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check RGNT's competition here
OSUR vs FEMY Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, FEMY has a market cap of 11.7M. Regarding current trading prices, OSUR is priced at $2.96, while FEMY trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas FEMY's P/E ratio is -0.84. In terms of profitability, OSUR's ROE is -0.19%, compared to FEMY's ROE of -5.35%. Regarding short-term risk, OSUR is less volatile compared to FEMY. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check FEMY's competition here
OSUR vs NXGL Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, NXGL has a market cap of 6.1M. Regarding current trading prices, OSUR is priced at $2.96, while NXGL trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas NXGL's P/E ratio is -1.51. In terms of profitability, OSUR's ROE is -0.19%, compared to NXGL's ROE of -0.61%. Regarding short-term risk, OSUR is less volatile compared to NXGL. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check NXGL's competition here
OSUR vs NSTG Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, OSUR is priced at $2.96, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas NSTG's P/E ratio is -0.03. In terms of profitability, OSUR's ROE is -0.19%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, OSUR is less volatile compared to NSTG. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check NSTG's competition here
OSUR vs LUCY Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, LUCY has a market cap of 4.3M. Regarding current trading prices, OSUR is priced at $2.96, while LUCY trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas LUCY's P/E ratio is -0.57. In terms of profitability, OSUR's ROE is -0.19%, compared to LUCY's ROE of -0.00%. Regarding short-term risk, OSUR is less volatile compared to LUCY. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check LUCY's competition here
OSUR vs NXGLW Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, NXGLW has a market cap of 4.3M. Regarding current trading prices, OSUR is priced at $2.96, while NXGLW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas NXGLW's P/E ratio is -0.04. In terms of profitability, OSUR's ROE is -0.19%, compared to NXGLW's ROE of -0.61%. Regarding short-term risk, OSUR is more volatile compared to NXGLW. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check NXGLW's competition here
OSUR vs POAI Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, POAI has a market cap of 2.9M. Regarding current trading prices, OSUR is priced at $2.96, while POAI trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas POAI's P/E ratio is -0.03. In terms of profitability, OSUR's ROE is -0.19%, compared to POAI's ROE of +29.59%. Regarding short-term risk, OSUR is less volatile compared to POAI. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check POAI's competition here
OSUR vs MHUA Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, OSUR is priced at $2.96, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas MHUA's P/E ratio is 0.25. In terms of profitability, OSUR's ROE is -0.19%, compared to MHUA's ROE of +0.06%. Regarding short-term risk, OSUR is more volatile compared to MHUA. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check MHUA's competition here
OSUR vs GMVD Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, OSUR is priced at $2.96, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas GMVD's P/E ratio is -0.01. In terms of profitability, OSUR's ROE is -0.19%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, OSUR is less volatile compared to GMVD. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check GMVD's competition here
OSUR vs GMVDW Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, OSUR is priced at $2.96, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas GMVDW's P/E ratio is N/A. In terms of profitability, OSUR's ROE is -0.19%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, OSUR is less volatile compared to GMVDW. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check GMVDW's competition here
OSUR vs AVGR Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, OSUR is priced at $2.96, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas AVGR's P/E ratio is -0.05. In terms of profitability, OSUR's ROE is -0.19%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, OSUR is less volatile compared to AVGR. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check AVGR's competition here
OSUR vs GCTK Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, GCTK has a market cap of 377.1K. Regarding current trading prices, OSUR is priced at $2.96, while GCTK trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas GCTK's P/E ratio is -0.02. In terms of profitability, OSUR's ROE is -0.19%, compared to GCTK's ROE of -3.93%. Regarding short-term risk, OSUR is less volatile compared to GCTK. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check GCTK's competition here
OSUR vs LUCYW Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, LUCYW has a market cap of 320.5K. Regarding current trading prices, OSUR is priced at $2.96, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas LUCYW's P/E ratio is N/A. In terms of profitability, OSUR's ROE is -0.19%, compared to LUCYW's ROE of -0.00%. Regarding short-term risk, OSUR is less volatile compared to LUCYW. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check LUCYW's competition here
OSUR vs WOK Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, WOK has a market cap of 7.4K. Regarding current trading prices, OSUR is priced at $2.96, while WOK trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas WOK's P/E ratio is N/A. In terms of profitability, OSUR's ROE is -0.19%, compared to WOK's ROE of -0.07%. Regarding short-term risk, OSUR is less volatile compared to WOK. This indicates potentially lower risk in terms of short-term price fluctuations for OSUR.Check WOK's competition here
OSUR vs APR Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, APR has a market cap of 0. Regarding current trading prices, OSUR is priced at $2.96, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas APR's P/E ratio is 22.59. In terms of profitability, OSUR's ROE is -0.19%, compared to APR's ROE of +9.81%. Regarding short-term risk, OSUR is more volatile compared to APR. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check APR's competition here
OSUR vs IIN Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, IIN has a market cap of 0. Regarding current trading prices, OSUR is priced at $2.96, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas IIN's P/E ratio is 226.45. In terms of profitability, OSUR's ROE is -0.19%, compared to IIN's ROE of -0.00%. Regarding short-term risk, OSUR is more volatile compared to IIN. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check IIN's competition here
OSUR vs ARTC Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, ARTC has a market cap of 0. Regarding current trading prices, OSUR is priced at $2.96, while ARTC trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas ARTC's P/E ratio is N/A. In terms of profitability, OSUR's ROE is -0.19%, compared to ARTC's ROE of N/A. Regarding short-term risk, OSUR is more volatile compared to ARTC. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check ARTC's competition here
OSUR vs ALOG Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, ALOG has a market cap of 0. Regarding current trading prices, OSUR is priced at $2.96, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas ALOG's P/E ratio is N/A. In terms of profitability, OSUR's ROE is -0.19%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, OSUR is more volatile compared to ALOG. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check ALOG's competition here
OSUR vs IVTY Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, IVTY has a market cap of 0. Regarding current trading prices, OSUR is priced at $2.96, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas IVTY's P/E ratio is N/A. In terms of profitability, OSUR's ROE is -0.19%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, OSUR is more volatile compared to IVTY. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check IVTY's competition here
OSUR vs HRC Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, HRC has a market cap of 0. Regarding current trading prices, OSUR is priced at $2.96, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas HRC's P/E ratio is 41.92. In terms of profitability, OSUR's ROE is -0.19%, compared to HRC's ROE of +0.14%. Regarding short-term risk, OSUR is more volatile compared to HRC. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check HRC's competition here
OSUR vs ATRS Comparison April 2026
OSUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSUR stands at 204.6M. In comparison, ATRS has a market cap of 0. Regarding current trading prices, OSUR is priced at $2.96, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSUR currently has a P/E ratio of -3.15, whereas ATRS's P/E ratio is 14.95. In terms of profitability, OSUR's ROE is -0.19%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, OSUR is more volatile compared to ATRS. This indicates potentially higher risk in terms of short-term price fluctuations for OSUR.Check ATRS's competition here